EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of Wnt/β‐Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells

Sarah Adriana Scuderi, Alessio Ardizzone, Deborah Mannino, Nicoletta Palermo, Fabiola De Luca, Antonio Catalfamo, Michela Campolo, Emanuela Esposito iD, Irene Paterniti

Journal of Cellular and Molecular Medicine · 2026-02 · 30 (4)

DOI: 10.1111/jcmm.70979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 16.02.2026. Verfasst von Sarah Adriana Scuderi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Pharmacogenetics Unit, "Gaetano Martino" University Hospital, Messina, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Temozolomide, Wnt Signaling Pathway, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GB) is a highly aggressive brain tumour with a poor prognosis and limited responsiveness to standard chemotherapy, particularly temozolomide (TMZ), due to intrinsic resistance mechanisms. This study investigates the potential of Aesculus hippocastanum , known as horse chestnut extract (HCE), to enhance the therapeutic efficacy of TMZ in GB cells through modulation of the Wnt/β‐catenin signalling pathway. Combined treatment of HCE (500 μg/mL) and TMZ (100 μM) significantly reduced cell viability and inhibited wound healing and colony formation compared to either agent alone at 48 h. Notably, the expression of β‐catenin and Wnt‐1 was significantly reduced in the combination group, followed by a significant downregulation of Nestin and β3‐tubulin, markers of glioma stem‐like cells and aggressiveness, respectively. Furthermore, apoptotic activity was significantly increased following the combined treatment. In a 3D U87‐spheroid model, the combination therapy resulted in a substantial reduction in spheroid area, suggesting impaired tumour growth. Propidium iodide (PI) staining revealed increased membrane permeability in cells treated with the combination, which was accompanied by an increase in p53 expression, supporting the induction of apoptosis. Collectively, these findings demonstrate that HCE increases the cytotoxic effects of TMZ by inhibiting Wnt/β‐catenin signalling, reducing tumour stemness, and promoting apoptotic pathways in GB cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTemozolomideWnt Signaling PathwayPlant ExtractsAesculusBrain NeoplasmsHumansCell Line, TumorApoptosisbeta CateninCell SurvivalCell ProliferationGene Expression Regulation, NeoplasticDrug Synergism

Stichwörter der Autor:innen

Aesculus hippocastanumWnt/β‐catenin signalling pathwaychemotherapyglioblastoma (GB)horse chestnut extract (HCE)temozolomide (TMZ)

Substanzen

TemozolomidePlant Extractsbeta Catenin

Autor:innen und Institutionen

  • Genetics and Pharmacogenetics Unit, "Gaetano Martino" University Hospital, Messina, Italy.
  • UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
  • Research Operative Unit of Neuropharmacology and Translational Neurosciences, Oasi Research Institute, IRCCS, Italy.
  • Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.

ORCID-Profile: Emanuela Esposito

Zitieren

APA

Scuderi, S. A., Ardizzone, A., Mannino, D., Palermo, N., De Luca, F., Catalfamo, A., Campolo, M., Esposito, E., & Paterniti, I. (2026). Modulation of Wnt/β‐Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells. Journal of Cellular and Molecular Medicine, 30(4). https://doi.org/10.1111/jcmm.70979

Vancouver

Scuderi SA, Ardizzone A, Mannino D, Palermo N, De Luca F, Catalfamo A, et al. Modulation of Wnt/β‐Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells. Journal of Cellular and Molecular Medicine. 2026;30(4). doi:10.1111/jcmm.70979

BibTeX
@article{Scuderi2026,
  author = {Scuderi, Sarah Adriana and Ardizzone, Alessio and Mannino, Deborah and Palermo, Nicoletta and De Luca, Fabiola and Catalfamo, Antonio and Campolo, Michela and Esposito, Emanuela and Paterniti, Irene},
  title = {Modulation of Wnt/β‐Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {4},
  doi = {10.1111/jcmm.70979}
}
Kostenlos starten →